ENTA Competitors & Alternatives
Compare Enanta Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ENTA
Main Stock$12.95
Tradestie Score
54
Market Cap
$226.82M
Revenue Growth
0.2%
Analyst Upside
+63.4%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$73.78
|
$410.79M | - | 49 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$10.09
|
$407.71M | - | 55 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$12.76
|
$386.68M | - | 52 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.04
|
$382.04M | - | 51 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$11.92
|
$371.64M | - | 58 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$16.25
|
$354.45M | - | 55 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$42.84
|
$353.70M | - | 54 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.00
|
$341.56M | - | 47 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.25
|
$332.96M | - | 51 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.91
|
$328.62M | - | 47 | Compare |
More ENTA Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry